{"id":60137,"date":"2024-02-28T06:35:09","date_gmt":"2024-02-28T06:35:09","guid":{"rendered":"https:\/\/medsname.com\/psyquit\/"},"modified":"2026-05-01T10:49:15","modified_gmt":"2026-05-01T10:49:15","slug":"psyquit","status":"publish","type":"product","link":"https:\/\/medsbase.com\/nl\/psyquit\/","title":{"rendered":"Psyquit"},"content":{"rendered":"

<\/p>\n

\n

⚡ Quick Answer — What is Psyquit?<\/h3>\n
\n

Psyquit<\/strong> bevat quetiapine 25 \/ 100 \/ 200 mg (immediate-release)<\/strong> from a WHO-GMP certified manufacturer (Sun Pharma) — an atypische antipsychotica<\/strong> with broad use across schizophrenia, bipolar disorder, and treatment-resistant depression. Mechanism: D2 + 5-HT2A<\/sub> antagonism plus prominent H1<\/sub> antihistamine action (heavy sedation) plus alpha-1 blockade (orthostasis). Doses span a huge range by indication: 25–100 mg HS<\/strong> (off-label insomnia, anxiety adjunct — controversial), 300–800 mg\/day<\/strong> (schizophrenia, bipolar mania), 150–300 mg\/day<\/strong> (bipolar depression, MDD adjunct). Major class warnings<\/strong>: metabolic syndrome (weight, glucose, lipids — class effect), heavy sedation, orthostatic hypotension, QT prolongation, EPS (lower than first-generation antipsychotics), and FDA black box for elderly dementia mortality<\/strong>.<\/p>\n<\/div>\n

\nWat u krijgt bij MedsBase:<\/strong> WHO-GMP gecertificeerde fabrikant \u00b7 Discrete verpakking \u00b7 Wereldwijde verzending \u00b7 1.400+ geverifieerde klantbeoordelingen<\/a>\n<\/div>\n

\ud83d\udce6 Elke bestelling is gedekt door onze Reshipment Assurance Policy<\/strong><\/a> \u2014 als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.<\/p>\n

Waarom bestellen bij MedsBase<\/h3>\n

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen \u2014 geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor \u2014 nooit \u201cMedsBase\u201d of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.<\/p>\n<\/div>\n

Important — this is not a situational-anxiety medication.<\/strong> Psyquit is a atypische antipsychotica<\/strong>, prescribed and titrated over weeks for schizophrenia, bipolar mania and depression, bipolar maintenance, and adjunctive treatment of major depressive disorder<\/strong>. It is niet<\/strong> the right drug for acute, performance-related anxiety (flying, public speaking, exams) — for those use cases beta-blockers (propranolol), benzodiazepines, or hydroxyzine are clinically appropriate. If you do not have a diagnosed mood, anxiety, or psychiatric disorder, do not start this medication.<\/div>\n
FDA black-box warning — elderly dementia mortality.<\/strong> All antipsychotics (atypical and conventional) carry an FDA black-box warning for increased mortality when used to treat dementia-related psychosis or behavioural disturbance in elderly patients. This medication is niet goedgekeurd<\/strong> for dementia-related symptoms.<\/div>\n

What Is Psyquit?<\/h2>\n

Psyquit is an oral immediate-release tablet of quetiapine fumarate 25 \/ 100 \/ 200 mg<\/strong> manufactured by Sun Pharma. Quetiapine (US brand Seroquel IR \/ Seroquel XR<\/strong>) is an atypical (second-generation) antipsychotic launched by AstraZeneca in 1997. It is a D2<\/sub> en 5-HT2A<\/sub> antagonist with strong H1<\/sub> antihistamine and moderate alpha-1 antagonist activity<\/strong>. The H1<\/sub> blockade drives the prominent sedation; the alpha-1 blockade drives orthostatic hypotension; the 5-HT2A<\/sub> antagonism reduces extrapyramidal side-effect risk compared with first-generation antipsychotics.<\/p>\n

The IR (immediate-release)<\/strong> formulation reaches peak plasma in 1–2 hours, producing prompt sedation. Dose timing matters — sedation 1–3 hours after the dose can be either useful (insomnia adjunct) or limiting (daytime fatigue).<\/p>\n

Goedgekeurde indicaties<\/h2>\n